Gabapentin Capsule
Product Images NDC 72162-1813

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72162-1813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Gabapentin Capsules Usp 1)

This text provides a formula to estimate the creatinine clearance rate for adults using their age and weight, along with a serum creatinine measurement. The formula is (140 - age in years) multiplied by weight in kilograms, then divided by serum creatinine in milligrams per deciliter, adjusted by 0.85 for female patients.*

FDA Label Image

Chem Structure (Gabapentin Capsules Usp 2)

FDA Label Image

10 (Gabapentin Capsules Usp 3)

FDA Label Image

10 (Gabapentin Capsules Usp 4)

FDA Label Image

10 (Gabapentin Capsules Usp 5)

FDA Label Image

Figure 4 (Gabapentin Capsules Usp 6)

FDA Label Image

Label (Lbl721621813)

Gabapentin Capsules, USP with a concentration of 300 mg per capsule, packaged in quantities of 90 capsules with an NDC of 72162-1813-9. It is important to keep all medications, including this one, out of reach of children. It is recommended to store it at a temperature between 20°C to 25°C and avoid excursions between 15°C to 30°C. This medication may cause dizziness. Manufactured by Amneal Pharmaceuticals Private Ltd and repackaged by Bryant Ranch Prepack Inc. Only available by prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.